angiotensin ii has been researched along with sc 560 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Baber, SR; Hyman, AL; Kadowitz, PJ | 1 |
Chabrashvili, T; Wang, D; Wilcox, CS | 1 |
Antonioli, L; Aydinoglu, F; Bernardini, N; Blandizzi, C; Colucci, R; Duranti, E; Fornai, M; Ippolito, C; Neves, MF; Rugani, I; Solini, A; Taddei, S; Virdis, A | 1 |
Asirvatham-Jeyaraj, N; Fink, GD; King, AJ; Madan, S; Northcott, CA | 1 |
5 other study(ies) available for angiotensin ii and sc 560
Article | Year |
---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Role of COX-1 and -2 in prostanoid generation and modulation of angiotensin II responses.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Angiotensin II; Animals; Arachidonic Acid; Blood Pressure; Cardiac Catheterization; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Isoenzymes; Membrane Proteins; Nitrobenzenes; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pulmonary Circulation; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Enhanced contractility of renal afferent arterioles from angiotensin-infused rabbits: roles of oxidative stress, thromboxane prostanoid receptors, and endothelium.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 8,11,14-Eicosatrienoic Acid; Angiotensin II; Animals; Arterioles; Bridged Bicyclo Compounds, Heterocyclic; Cyclic N-Oxides; Cyclooxygenase 2; Dose-Response Relationship, Drug; Endothelin-1; Endothelins; Endothelium, Vascular; Isoenzymes; Kidney; Male; Nitroarginine; Norepinephrine; Oxazoles; Oxidative Stress; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rabbits; Receptors, Thromboxane; RNA, Messenger; Spin Labels; Superoxides; Vascular Resistance; Vasoconstriction | 2004 |
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition.
Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Angiotensin II; Animals; Biomechanical Phenomena; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Collagen Type I; Coronary Vessels; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dinoprost; Elastin; Fatty Acids, Unsaturated; Fibronectins; Humans; Hydrazines; Immunohistochemistry; Male; Mesenteric Arteries; Mice; Mice, Knockout; Pyrazoles; Vascular Resistance | 2012 |
Cyclooxygenase-1 inhibition attenuates angiotensin II-salt hypertension and neurogenic pressor activity in the rat.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Ganglionic Blockers; Hypertension; Ketoprofen; Male; Membrane Proteins; Norepinephrine; Pyrazoles; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Sulfonamides; Sympathetic Nervous System; Time Factors | 2013 |